Fig. 2From: The effect of renin–angiotensin–aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trialsSummary of the Risk of Bias of the Included StudiesBack to article page